Two popular options, Sermorelin and Semaglutide, are catching attention for their different ways of helping with weight management
Many pharmaceutical companies have decided that the benefits outweigh the risks
The study found that, over a 68-week period, participants receiving semaglutide lost, on average, 14.9% of their body weight compared to 2.4% in the placebo group
Youll know what to expect before your first dose not after
Novo Nordisk came out swinging against the rival pill
For semaglutide alone, trials relating to cardiovascular disease (SELECT), kidney disease (FLOW) and heart failure (STEP) have announced positive results in the last 12 months